Corimmun

company

About

Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.

Details

Last Funding Type
Seed
Last Funding Money Raised
€680K
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2006
Operating Status
Active

Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€680K
Corimmun has raised a total of €680K in funding over 2 rounds. Their latest funding was raised on Jan 22, 2007 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 22, 2007 Seed €680K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Corimmun is funded by 1 investors. Bayern Kapital are the most recent investors.
Investor Name Lead Investor Funding Round
Bayern Kapital Seed